The Cost of Cancer Treatment Study's Design and Methods
Abstract
Clinical cancer trials are supported by a combination of research sponsors, institutions, and third-party payers. However, it is unclear what additional costs-if any-are associated with treatment in a government-sponsored cancer trial. The National Cancer Institute, the National Institutes of Health, and the White House Office of Science and Technology Policy have a strong interest in estimating these costs so that informed policy decisions can be made about how to finance clinical trial research. This report documents the design and methods of the Cost of Cancer Treatment Study (see www.costofcancer.org), a retrospective study designed to provide precise and generalizable estimates of the additional costs, if any, associated with clinical cancer research. Principal funding comes from the National Cancer Institute, with additional funding from the Office of the Director, National Institutes of Health, and from the National Science Foundation, as part of its support for the White House's Office of Science and Technology Policy. These offices as well as individuals in the cancer research community will be interested in this report on the design and methods of the study and the results of the study itself.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 2000
- Accession Number
- ADA381253
Entities
People
- Dana P. Goldman
- John L. Adams
- Jose J. Escarce
- Meredith L. Kilgore
- Sandra H. Berry
Organizations
- RAND Corporation